DSP Healthcare Fund Direct Growth

Fund Overview

Fund Size

₹3,094 Cr

Expense Ratio

0.60%

ISIN

INF740KA1LG1

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

30 Nov 2018

About this fund

DSP Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by DSP Mutual Fund. This fund has been in existence for 5 years, 10 months and 23 days, having been launched on 30-Nov-18.
As of 22-Oct-24, it has a Net Asset Value (NAV) of ₹44.26, Assets Under Management (AUM) of 3094.08 Crores, and an expense ratio of 0.6%.

DSP Healthcare Fund Direct Growth has given a CAGR return of 28.71% since inception.
The fund's asset allocation comprises around 96.72% in equities, 0.00% in debts, and 3.28% in cash & cash equivalents.
You can start investing in DSP Healthcare Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+55.66%

+53.19% (Cat Avg.)

3 Years

+23.04%

+19.61% (Cat Avg.)

5 Years

+33.78%

+28.48% (Cat Avg.)

Since Inception

+28.71%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2024

Equity	₹2,992.58 Cr	96.72%
Others	₹101.5 Cr	3.28%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹361.34 Cr	11.68%
Suven Pharmaceuticals Ltd	Equity	₹303.33 Cr	9.80%
Ipca Laboratories Ltd	Equity	₹240.29 Cr	7.77%
Lupin Ltd	Equity	₹239.39 Cr	7.74%
Cipla Ltd	Equity	₹229.27 Cr	7.41%
Alembic Pharmaceuticals Ltd	Equity	₹171.61 Cr	5.55%
Globus Medical Inc Class A	Equity	₹161.12 Cr	5.21%
Illumina Inc	Equity	₹152.32 Cr	4.92%
Apollo Hospitals Enterprise Ltd	Equity	₹134.05 Cr	4.33%
Treps / Reverse Repo Investments	Cash - Repurchase Agreement	₹120.39 Cr	3.89%
Concord Biotech Ltd	Equity	₹118.69 Cr	3.84%
Vijaya Diagnostic Centre Ltd	Equity	₹97.76 Cr	3.16%
Kovai Medical Center & Hospital Ltd	Equity	₹87.05 Cr	2.81%
Procter & Gamble Health Ltd	Equity	₹86.11 Cr	2.78%
Pfizer Ltd	Equity	₹82.48 Cr	2.67%
Indoco Remedies Ltd	Equity	₹81.6 Cr	2.64%
Intuitive Surgical Inc	Equity	₹77.25 Cr	2.50%
Gland Pharma Ltd	Equity	₹63.93 Cr	2.07%
ICICI Lombard General Insurance Co Ltd	Equity	₹52.49 Cr	1.70%
Unichem Laboratories Ltd	Equity	₹48.41 Cr	1.56%
Aarti Drugs Ltd	Equity	₹37.6 Cr	1.22%
Narayana Hrudayalaya Ltd	Equity	₹37.26 Cr	1.20%
Abbott Laboratories	Equity	₹30.19 Cr	0.98%
Emcure Pharmaceuticals Ltd	Equity	₹23.84 Cr	0.77%
Global X Genomics & Biotechnology ETF	Mutual Fund - ETF	₹23.09 Cr	0.75%
Alkem Laboratories Ltd	Equity	₹22.6 Cr	0.73%
Net Receivables/Payables	Cash	₹-18.91 Cr	0.61%
Jupiter Life Line Hospitals Ltd	Equity	₹13.64 Cr	0.44%
Medplus Health Services Ltd	Equity	₹12.88 Cr	0.42%
Thyrocare Technologies Ltd	Equity	₹1.98 Cr	0.06%
GRAIL Inc	Equity	₹1.01 Cr	0.03%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹2,917.01 Cr	94.28%
Financial Services	₹52.49 Cr	1.70%

Risk & Performance Ratios

Fund Managers

Chirag Dagli

Since December 2020

Additional Scheme Detailsas of 30th September 2024

ISIN

INF740KA1LG1

Expense Ratio

0.60%

Exit Load

No Charges

Fund Size

₹3,094 Cr

Age

5 years 10 months

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.2%	-	₹21.04 Cr	54.2%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹888.27 Cr	52.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹888.27 Cr	50.5%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹39.61 Cr	52.4%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹201.94 Cr	53.3%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹201.94 Cr	50.4%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹2793.61 Cr	53.2%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.9%	1.0%	₹2793.61 Cr	50.9%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹851.53 Cr	51.7%
Axis NIFTY Healthcare ETF Very High Risk	0.3%	-	₹19.51 Cr	51.3%

About the AMC

DSP Mutual Fund

+91 18002084499

https://www.dspim.com/

Total AUM

₹1,82,497 Cr

Address

West Wing, 11th Floor, Mumbai, 400021

Other Funds by DSP Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
DSP Multicap Fund Direct Growth Low Risk	0.5%	1.0%	₹1663.70 Cr	-
DSP Nifty Smallcap250 Quality 50 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹152.80 Cr	-
DSP Banking & Financial Services Fund Direct Growth Very High Risk	0.7%	0.0%	₹978.54 Cr	-
DSP Gold ETF Fund of Fund Direct Growth High Risk	0.6%	0.0%	₹38.41 Cr	-
DSP Multi Asset Allocation Fund Direct Growth Very High Risk	0.3%	1.0%	₹2194.59 Cr	29.8%
DSP FMP - Series 264 - 60M - 17D Direct Growth Low to Moderate Risk	-	0.0%	₹48.86 Cr	9.0%
DSP FMP Series 267 - 1246 Days Direct Growth Low to Moderate Risk	-	0.0%	₹656.19 Cr	8.5%
DSP FMP Series 261 37 Month Direct Growth Moderate Risk	-	-	-	-
DSP Fixed Maturity Plan Series 270 1144 Days Direct Growth Low to Moderate Risk	-	0.0%	-	8.5%
DSP FMP Series 268 - 1281 Days Direct Growth Low to Moderate Risk	-	-	-	8.6%
DSP FMP Series 252 38 Month Direct Growth Moderate Risk	-	0.0%	-	-
DSP Banking & PSU Debt Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹2914.36 Cr	9.7%
DSP Dynamic Asset Allocation Fund Direct Growth Moderate Risk	0.7%	1.0%	₹3259.27 Cr	22.4%
DSP Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹2929.10 Cr	6.8%
DSP Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹661.52 Cr	26.4%
DSP Nifty Next 50 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹844.26 Cr	60.1%
DSP Healthcare Fund Direct Growth Very High Risk	0.6%	0.0%	₹3094.08 Cr	55.7%
DSP Global Allocation Fund Direct Growth Very High Risk	1.4%	0.0%	₹55.49 Cr	23.8%
DSP Low Duration Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹5149.20 Cr	7.8%
DSP Value Fund Direct Growth Very High Risk	0.9%	1.0%	₹940.10 Cr	40.9%
DSP Nifty SDL Plus G-Sec Jun 2028 30:70 Index Fund Direct Growth Moderate Risk	0.2%	0.0%	₹2240.38 Cr	9.3%
DSP Bond Fund Direct Growth Moderately High risk	0.4%	0.0%	₹376.03 Cr	8.7%
DSP Flexi Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹12415.55 Cr	36.1%
DSP Government Securities Direct Growth Moderate Risk	0.6%	0.0%	₹1417.52 Cr	12.9%
DSP Equity & Bond Fund Direct Growth Very High Risk	0.7%	1.0%	₹10610.03 Cr	30.7%
DSP Focus Fund Direct Growth Very High Risk	1.0%	1.0%	₹2703.98 Cr	39.6%
DSP Credit Risk Fund Direct Growth Moderately High risk	0.4%	1.0%	₹188.00 Cr	8.8%
DSP India TIGER Fund Direct Growth Very High Risk	0.8%	1.0%	₹5645.88 Cr	57.3%
DSP Liquidity Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹22611.12 Cr	7.5%
DSP Regular Saving Fund Direct Growth Moderately High risk	0.5%	0.0%	₹180.98 Cr	15.5%
DSP Small Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹16704.97 Cr	33.6%
DSP Ultra Short Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹3033.50 Cr	7.7%
DSP Short Term Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹2885.79 Cr	8.6%
DSP Midcap Fund Direct Growth Very High Risk	0.7%	1.0%	₹20237.46 Cr	38.3%
DSP Natural Resource & New Energy Fund Direct Growth Very High Risk	1.0%	0.0%	₹1335.59 Cr	44.4%
DSP Equity Opportunities Fund Direct Growth Very High Risk	0.7%	1.0%	₹14485.57 Cr	45.0%
DSP Strategic Bond Fund Direct Growth Moderate Risk	0.5%	0.0%	₹1815.53 Cr	12.3%
DSP Savings Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹4416.25 Cr	7.7%
DSP Tax Saver Fund Direct Growth Very High Risk	0.7%	0.0%	₹17770.63 Cr	44.9%
DSP World Agriculture Direct Growth Very High Risk	1.5%	0.0%	₹12.18 Cr	7.1%
DSP Top 100 Equity Fund Direct Growth Very High Risk	1.1%	1.0%	₹4613.49 Cr	38.4%
DSP US Flexible Equity Fund Direct Growth Very High Risk	1.5%	0.0%	₹908.58 Cr	27.4%
DSP World Energy Direct Growth Very High Risk	1.5%	0.0%	₹139.15 Cr	19.9%
DSP World Gold Fund of Fund Direct Growth Very High Risk	1.6%	0.0%	₹1098.04 Cr	47.9%
DSP World Mining Direct Growth Very High Risk	1.5%	0.0%	₹142.41 Cr	20.4%
DSP Equity Savings Fund Direct Growth Moderate Risk	0.5%	0.0%	₹1936.65 Cr	18.3%
DSP Arbitrage Fund Direct Growth Low Risk	0.3%	0.0%	₹6121.53 Cr	8.1%
DSP Corporate Bond Fund Direct Growth Moderate Risk	0.3%	0.0%	₹2548.64 Cr	8.3%
DSP 10Y G-Sec Fund Direct Growth Moderate Risk	0.3%	0.0%	₹56.31 Cr	10.5%
DSP Nifty SDL Plus G-Sec Sep 2027 50:50 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹91.87 Cr	9.2%

Risk Level

Your principal amount will be at Very High Risk

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

What is the current NAV of DSP Healthcare Fund Direct Growth?

The NAV of DSP Healthcare Fund Direct Growth, as of 22-Oct-2024, is ₹44.26.

What are the returns of DSP Healthcare Fund Direct Growth?

The fund has generated 55.66% over the last 1 year and 23.04% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of DSP Healthcare Fund Direct Growth?

The fund's allocation of assets is distributed as 96.72% in equities, 0.00% in bonds, and 3.28% in cash and cash equivalents.

Who manages the DSP Healthcare Fund Direct Growth?

The fund managers responsible for DSP Healthcare Fund Direct Growth are:-

Chirag Dagli

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Our weekly expert newsletter on stories that matter to your money.

Knowledge Repository

Bonds

IPA

Mutual Funds

Portfolio Management Services

About

Investment Philosophy

Legal

Returns & Cancellation

Security

Terms & Disclosure

KYC Check

©2021-2022 Dezerv. All Rights Reserved

Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

DSP Healthcare Fund Direct Growth

Fund Overview